Copy of Newspaper Publication

November 06, 2026 To, To, The Listing Department, The Listing Department BSE Limited, National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (East), Mumbai – 400051 Scrip code: 544889 Symbol: SYMBIOTEC Sub.: Newspaper advertisement regarding Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 Ref.: 1. Regulation 30 & 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 2. Outcome of the Board Meeting dated November 05, 2026 Dear Sir / Madam, With reference to the captioned subject, please find enclosed the copies of the Newspaper advertisement with respect to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 as published in following newspapers dated November 06, 2026. i. Business Standard [English – All Editions] and ii. Patrika [Hindi – Indore Edition] The above information is being made available on website of the Company i.e. https://investor.symbiotec.com/announcements?tab=reg30 Kindly take the same on record and oblige. Thanking You. Sincerely, For Symbiotec Pharmalab Limited Salil Jain Company Secretary and Compliance Officer Membership No. A41610 Encl: As above Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293